Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

High RiskFDA Food
Food & Beverages/Dietary Supplements

Notoginseng Formula Special Gout Granule Recalled for Undeclared Drugs

Agency Publication Date: January 31, 2024
Share:
Sign in to monitor this recall

Summary

8th Ave Pharmacy is recalling approximately 5,600 units of Notoginseng Formula Special Gout Granule, which was marketed as a 100% natural supplement. Testing found the product contains undeclared Diclofenac and Dexamethasone Acetate, which are prescription drug ingredients not listed on the label. Consumers who purchased this product should stop using it and return it to the place of purchase for a refund.

Risk

The undeclared presence of Diclofenac (an NSAID) and Dexamethasone (a corticosteroid) poses serious health risks, including potential stomach bleeding, liver damage, or severe interactions with other medications. No injuries or illnesses have been reported to date.

What You Should Do

  1. This recall affects Notoginseng Formula Special Gout Granule sold in boxes of ten 8-gram packs under the Citi Trade Int'l Limited label. All product codes and dates are included in this recall.
  2. Stop using the recalled product immediately. Return the product to the place of purchase for a refund, throw it away, or contact 8th Ave Pharmacy for further instructions.
  3. If you have questions about this recall, call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Return the product to the place of purchase for a full refund, or contact the manufacturer or supplier for further instructions
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away.

Affected Products

Product: Notoginseng Formula Special Gout Granule (8 G x 10 PACKS)by Citi Trade Int'l Limited
Lot Numbers:
All codes.

Distributed by Citi Trade Int'l Limited; marketed for gout and uric acid detoxification.

Product Images

Image โ€“ Labeling, Notoginseng Formula Special Gout Granule

Image โ€“ Labeling, Notoginseng Formula Special Gout Granule

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 93618
Status: Resolved
Manufacturer: 8TH AVE PHARMACY
Sold By: 8TH AVE PHARMACY
Manufactured In: United States
Units Affected: 5600 units
Distributed To: Alabama, Colorado, Florida, Georgia, Hawaii, Illinois, Indiana, Louisiana, Maryland, Michigan, Minnesota, Missouri, Mississippi, North Carolina, New Jersey, Nevada, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท FDA Press Release ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.